Name | 3-chloro-5-{[5-chloro-1-(1H-pyrazolo[3,4-b]pyridin-3-ylmethyl)-1H-indazol-4-yl]oxy}benzonitrile |
---|
Description | MK-6186 is a novel non-nucleoside reverse transcriptase inhibitor with antiviral activity for the study of viral infections. |
---|---|
In Vitro | MK-6186 showed FCs of <10 against EFV or etravirine (ETR) and the mutant viruses containing mutations selected by EFV or ETR were sensitive to MK-6186 (FCs of <10).[1] |
References | 1. Lu M, et al. Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor. Antimicrob Agents Chemother. 2012 Jun;56(6):3324-35. |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 656.4±55.0 °C at 760 mmHg |
Molecular Formula | C21H12Cl2N6O |
Molecular Weight | 435.266 |
Flash Point | 350.8±31.5 °C |
Exact Mass | 434.044952 |
PSA | 92.41000 |
LogP | 4.86 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.763 |